2025
Understanding Provider Treatment Approaches for the Provision of Gender-Affirming Hormones in the Current US Political Climate.
Stetten N, Kelly P, Shireman T, Balkan E, Babbs G, Alpert A, Wolfe H, Meyers D, Hughto J. Understanding Provider Treatment Approaches for the Provision of Gender-Affirming Hormones in the Current US Political Climate. American Journal Of Public Health 2025, 115: 1598-1601. PMID: 40811777, PMCID: PMC12424504, DOI: 10.2105/ajph.2025.308143.Peer-Reviewed Original ResearchConceptsGender-affirming hormone therapyPatient's medical historyPatient goalsStandard of careHormone therapyGender-affirming hormonesMedical historyCisgender patientsSocial supportConsent modelsPatientsTreatment approachesUS political climateUS providersClinical standardsOpen communicationProvidersPolitical climatePeople's access
2023
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry
Robbins C, Fernandez A, Han G, Wong S, Harigopal M, Podoll M, Singh K, Ly A, Kuba M, Wen H, Sanders M, Brock J, Wei S, Fadare O, Hanley K, Jorns J, Snir O, Yoon E, Rabe K, Soong T, Reisenbichler E, Rimm D. Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry. Modern Pathology 2023, 36: 100032. PMID: 36788069, PMCID: PMC10278086, DOI: 10.1016/j.modpat.2022.100032.Peer-Reviewed Original ResearchConceptsOverall percent agreementHuman epidermal growth factor 2HER2 IHCReal-world settingEpidermal growth factor 2HER2-negative statusBreast cancer biopsiesCompanion diagnostic testsMulti-institutional assessmentGrowth factor 2Breast cancerImmunohistochemistry assaysCancer biopsiesHER2 immunohistochemistryPathologist concordanceIHCClinical standardsPercent agreementDiagnostic testsSubstantial discordanceERBB2 geneInterrater reliabilityPathologistsFactor 2Concordance
2021
Net zero healthcare: a call for clinician action
Sherman JD, McGain F, Lem M, Mortimer F, Jonas WB, MacNeill AJ. Net zero healthcare: a call for clinician action. The BMJ 2021, 374: n1323. PMID: 34544732, PMCID: PMC8450779, DOI: 10.1136/bmj.n1323.Peer-Reviewed Original Research
2020
Predicting risk of late age-related macular degeneration using deep learning
Peng Y, Keenan T, Chen Q, Agrón E, Allot A, Wong W, Chew E, Lu Z. Predicting risk of late age-related macular degeneration using deep learning. Npj Digital Medicine 2020, 3: 111. PMID: 32904246, PMCID: PMC7453007, DOI: 10.1038/s41746-020-00317-z.Peer-Reviewed Original ResearchLate age-related macular degenerationAge-related macular degenerationHigher prognostic accuracyClinical standardsMacular degenerationPrognostic accuracyIndependent cohortLargest longitudinal clinical trialsProbability of progressionSight-threatening stagesColor fundus photographsLongitudinal clinical trialsAMD patientsRetinal specialistsClinical trialsFundus photographsSpecialty clinicHigh riskClinical actionsSurvival analysisMedical interventionsIndividual riskAREDS2AREDSExternal validation
2019
EPID-23. PURSUIT OF AN INTERNATIONAL LANGUAGE OF GLIOMA RESEARCH: COMMON DATA ELEMENTS FOR THE LONGITUDINAL STUDY OF ADULT MALIGNANT GLIOMA
Poisson L, Kouwenhoven M, Snyder J, Alfaro-Munoz K, Kaur M, Bates A, Verhaak R, Watts C, Zadeh G, Ormond D, Claus E, Khasraw M. EPID-23. PURSUIT OF AN INTERNATIONAL LANGUAGE OF GLIOMA RESEARCH: COMMON DATA ELEMENTS FOR THE LONGITUDINAL STUDY OF ADULT MALIGNANT GLIOMA. Neuro-Oncology 2019, 21: vi79-vi79. PMCID: PMC6847827, DOI: 10.1093/neuonc/noz175.323.Peer-Reviewed Original ResearchAdult malignant gliomasCommon data elementsMalignant gliomasGlioma researchRetrospective chart abstractionLongitudinal studySmall patient populationMulti-center collaborationResearch Electronic Data Capture (REDCap) systemChart abstractionPatient demographicsClinical courseClinical featuresOngoing trialsClinical variablesPatient populationUncommon cancerMedical historyClinical dataTranslational studiesGlioma Longitudinal Analysis ConsortiumClinical standardsMultidisciplinary expertsConfirmatory studiesGliomasCrowdsourcing to delineate skin affected by chronic graft‐vs‐host disease
Tkaczyk E, Coco J, Wang J, Chen F, Ye C, Jagasia M, Dawant B, Fabbri D. Crowdsourcing to delineate skin affected by chronic graft‐vs‐host disease. Skin Research And Technology 2019, 25: 572-577. PMID: 30786065, PMCID: PMC6719554, DOI: 10.1111/srt.12688.Peer-Reviewed Original ResearchConceptsChronic graftHost diseaseAffected skinPercent body surface areaBody surface areaBoard-certified dermatologistsCurrent clinical standardMedian Dice indexCGVHD patientsPrimary outcomeImportant unmetAffected surface areaThree-dimensional photographsClinical standardsFleiss' kappaDiseaseSkinGraftPractical managementWeak correlationHigh agreementKappaConsensus delineationPatients
2016
Orthotic Management of Deformational Plagiocephaly: Consensus Clinical Standards of Care
Lin RS, Stevens PM, Wininger M, Castiglione CL. Orthotic Management of Deformational Plagiocephaly: Consensus Clinical Standards of Care. The Cleft Palate-Craniofacial Journal 2016, 53: 394-403. PMID: 26247705, DOI: 10.1597/15-007.Peer-Reviewed Original Research
2015
Identification of Medically Actionable Secondary Findings in the 1000 Genomes
Olfson E, Cottrell CE, Davidson NO, Gurnett CA, Heusel JW, Stitziel NO, Chen LS, Hartz S, Nagarajan R, Saccone NL, Bierut LJ. Identification of Medically Actionable Secondary Findings in the 1000 Genomes. PLOS ONE 2015, 10: e0135193. PMID: 26332594, PMCID: PMC4558085, DOI: 10.1371/journal.pone.0135193.Peer-Reviewed Original ResearchConceptsSecondary findingsAdditional truncating variantsRelevant secondary findingsCancer predisposition syndromeClinical laboratory specialistsActionable secondary findingsCardiac conditionsAmerican CollegeFamilial hypercholesterolemiaPredisposition syndromeAfrican ancestry groupPathogenic variantsTruncating variantsClinical standardsLiterature reviewActionable conditionsImportant secondary findingActionable findingsDiseaseACMG genesLaboratory specialistsUnderstudied populationAncestry groupsCandidate variantsExpert physiciansFeasibility of (18)F-Fluorodeoxyglucose radiotracer dose reduction in simultaneous carotid PET/MR imaging.
Eldib M, Bini J, Lairez O, Faul DD, Oesingmann N, Fayad ZA, Mani V. Feasibility of (18)F-Fluorodeoxyglucose radiotracer dose reduction in simultaneous carotid PET/MR imaging. American Journal Of Nuclear Medicine And Molecular Imaging 2015, 5: 401-7. PMID: 26269777, PMCID: PMC4529593.Peer-Reviewed Original ResearchLow doseMR imagingStandard clinical dosePET/MR imagingClinical doseStandard doseFDG doseCarotid plaquesDose reductionClinical standardsDoseTime pointsLow-dose acquisitionsDose acquisitionSimultaneous PET/MR imagingPreliminary findingsSimultaneous PET/MR scannerMR scannerPET acquisitionPET dataQualitative image quality evaluationsAcquisition protocolsLow levelsMinutesImaging
2004
Compliance with the Centers for Disease Control and Prevention Recommendations for the Diagnosis and Treatment of Sexually Transmitted Diseases
Kane BG, Degutis LC, Sayward HK, D'Onofrio G. Compliance with the Centers for Disease Control and Prevention Recommendations for the Diagnosis and Treatment of Sexually Transmitted Diseases. Academic Emergency Medicine 2004, 11: 371-377. PMID: 15064211, DOI: 10.1197/j.aem.2003.11.016.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnti-Bacterial AgentsCenters for Disease Control and Prevention, U.S.Chlamydia InfectionsEmergency Service, HospitalFemaleGonorrheaGuideline AdherenceHumansMalePatient DischargePatient Education as TopicPelvic Inflammatory DiseaseRetrospective StudiesSex DistributionSexually Transmitted DiseasesUnited StatesUrethritisUterine CervicitisConceptsPelvic inflammatory diseasePrevention recommendationsDisease controlRetrospective chart reviewTreatment of STDsICD-9 codesUrban teaching hospitalEmergency department practiceDocumentation of complianceChart reviewED visitsChlamydia casesCDC guidelinesDischarge instructionsPhysical examinationPrescribed antibioticsInflammatory diseasesPatient visitsTeaching hospitalED practiceED practitionersCervicitisDiagnostic testingUrethritisClinical standards
2002
COULD ADEQUATE PALLIATIVE CARE OBVIATE ASSISTED SUICIDE?
Curry L, Schwartz HI, Gruman C, Blank K. COULD ADEQUATE PALLIATIVE CARE OBVIATE ASSISTED SUICIDE? Death Studies 2002, 26: 757-774. PMID: 12385345, DOI: 10.1080/07481180290106535.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply